B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

NOS2

MOLECULAR TARGET

nitric oxide synthase 2

UniProt: P35228NCBI Gene: 484321 compounds

NOS2 (nitric oxide synthase 2) is targeted by 21 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting NOS2

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1tilarginine4.73112
2pimagedine4.5392
3l name3.7642
4l nil3.3728
5chlorzoxazone3.3026
61400w3.3026
7oleanonic acid3.1422
8bardoxolone3.0019
97 nitroindazole2.9418
102 aminopyridine2.8316
11Nitroarginine2.4811
12gigantol2.4010
13l nio2.208
14Arginine1.956
15Arginine1.956
16gw 2741501.956
17thiocitrulline1.956
18ethylisothiourea1.795
19NG-Nitroarginine Methyl Ester1.614
20alyssin [Supplementary Concept]0.691
21Guanethidine0.691

About NOS2 as a Drug Target

NOS2 (nitric oxide synthase 2) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 21 compounds with documented NOS2 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

NOS2 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.